Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 12 Jul 2010 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Mirae Asset Large & Midcap Fund |
|---|---|
| 12 Jul 2010 | ₹100.00 |
| 14 Nov 2011 | ₹106.35 |
| 19 Mar 2013 | ₹117.06 |
| 22 Jul 2014 | ₹184.51 |
| 24 Nov 2015 | ₹239.55 |
| 28 Mar 2017 | ₹270.00 |
| 01 Aug 2018 | ₹298.83 |
| 04 Dec 2019 | ₹310.41 |
| 07 Apr 2021 | ₹367.94 |
| 10 Aug 2022 | ₹406.18 |
| 14 Dec 2023 | ₹435.77 |
| 17 Apr 2025 | ₹452.00 |
| 20 Aug 2026 | ₹485.67 |
| Metric | Mirae Asset · Regular · IDCW NAV ₹48.89 Very High risk ★★★☆☆ | Category median Large & Mid Cap Fund · 35 funds |
|---|---|---|
| -1.66% | +3.02% | |
| +7.89% | +9.47% | |
| +2.77% | +9.57% | |
| +7.42% | +8.51% | |
| +10.31% | +8.27% | |
| +3.55% | — | |
| +11.97% | +10.05% | |
| +11.72% | +9.17% | |
| +11.35% | +6.32% | |
| Risk | ||
| 15.65% | 15.59% | |
| 0.09 | 0.10 | |
| 0.11 | 0.12 | |
| -41.77% | -42.76% | |
| Nifty Midcap 150 | — | |
| -7.23% | -5.64% | |
| 0.84 | 0.85 | |
| 73.7% | 79.3% | |
| 101.6% | 97.2% | |
| 1.78% | 2.30% | |
| ₹45,275Cr | ₹4,527Cr | |
| 1.00% | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| 63% | 40% | |
| Neelesh Surana · 13.6y | — | |
| 12 Jul 2010 | — | |
| 82 | — | |
| 31.6% | — | |
| 0.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.